SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001076809-24-000080
Filing Date
2024-03-18
Accepted
2024-03-18 17:35:47
Documents
1

Document Format Files

Seq Description Document Type Size
1 harp20240308.htm SC 13G 63388
  Complete submission text file 0001076809-24-000080.txt   65085
Mailing Address 250 WEST 55TH STREET SUITE 30A NEW YORK NY 10019
Business Address 250 WEST 55TH STREET SUITE 30A NEW YORK NY 10019 212-808-7308
GLAZER CAPITAL, LLC (Filed by) CIK: 0001076809 (see all company filings)

IRS No.: 134032491 | State of Incorp.: DE
Type: SC 13G

Mailing Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080 (650) 443-7400
Harpoon Therapeutics, Inc. (Subject) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90935 | Film No.: 24760265
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)